Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Colorectal Neoplasms 4Central Nervous System Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Osteosarcoma 2Lymphoma 2Gliosarcoma 2Glioblastoma 2Colonic Neoplasms 2Vomiting 1Radiation Injuries 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nausea 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma, Follicular 1Kidney Neoplasms 1Hodgkin Disease 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Cardiotoxicity 1Carcinoma, Renal Cell 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00493025 2018-12-06

Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
19 enrolled 4 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡